Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples